Matthew Harmon

660 total citations
18 papers, 339 citations indexed

About

Matthew Harmon is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Matthew Harmon has authored 18 papers receiving a total of 339 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 7 papers in Oncology and 4 papers in Surgery. Recurrent topics in Matthew Harmon's work include Prostate Cancer Treatment and Research (8 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Radiopharmaceutical Chemistry and Applications (3 papers). Matthew Harmon is often cited by papers focused on Prostate Cancer Treatment and Research (8 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Radiopharmaceutical Chemistry and Applications (3 papers). Matthew Harmon collaborates with scholars based in United States, India and United Kingdom. Matthew Harmon's co-authors include Sangamesh G. Kumbar, Roshan James, Daisy M. Ramos, Aja Aravamudhan, Namdev B. Shelke, Xiaojun Yu, Cato T. Laurencin, Meng Deng, Xiaojun Yu and Ahmed A. Nada and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and Journal of Applied Polymer Science.

In The Last Decade

Matthew Harmon

17 papers receiving 333 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Matthew Harmon United States	9	145	133	62	42	37	18	339
Marcos Augusto de Sá Brazil	11	158 1.1×	63 0.5×	43 0.7×	26 0.6×	14 0.4×	19	293
Xianfang Jiang China	8	150 1.0×	115 0.9×	53 0.9×	69 1.6×	10 0.3×	16	370
Gyeol Yoo South Korea	11	60 0.4×	184 1.4×	170 2.7×	61 1.5×	27 0.7×	33	589
Zhuowen Hao China	15	190 1.3×	123 0.9×	80 1.3×	166 4.0×	17 0.5×	23	486
Yonatan Shachaf Israel	8	158 1.1×	125 0.9×	103 1.7×	36 0.9×	41 1.1×	9	337
Shunyi Lu China	14	239 1.6×	112 0.8×	135 2.2×	143 3.4×	61 1.6×	43	611
Neelam Gurav United Kingdom	9	173 1.2×	82 0.6×	139 2.2×	29 0.7×	72 1.9×	17	331
R. Pace France	6	171 1.2×	128 1.0×	89 1.4×	25 0.6×	11 0.3×	7	339
Ronghang Li China	10	163 1.1×	121 0.9×	62 1.0×	46 1.1×	13 0.4×	17	326
Camille Dollinger France	9	177 1.2×	75 0.6×	137 2.2×	55 1.3×	8 0.2×	13	377

Countries citing papers authored by Matthew Harmon

Since Specialization

Citations

This map shows the geographic impact of Matthew Harmon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Harmon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Harmon more than expected).

Fields of papers citing papers by Matthew Harmon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew Harmon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Harmon. The network helps show where Matthew Harmon may publish in the future.

Co-authorship network of co-authors of Matthew Harmon

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew Harmon. A scholar is included among the top collaborators of Matthew Harmon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew Harmon. Matthew Harmon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Antonarakis, Emmanuel S., Sumit K. Subudhi, Christopher Pieczonka, et al.. (2023). Combination Treatment with Sipuleucel-T and Abiraterone Acetate or Enzalutamide for Metastatic Castration-Resistant Prostate Cancer: STAMP and STRIDE Trials. Clinical Cancer Research. 29(13). 2426–2434. 10 indexed citations

Wei, Xiao X., Lucia Kwak, Anis Hamid, et al.. (2022). Outcomes in men with metastatic castration-resistant prostate cancer who received sipuleucel-T and no immediate subsequent therapy: experience at Dana Farber and in the PROCEED Registry. Prostate Cancer and Prostatic Diseases. 25(2). 314–319. 8 indexed citations

Harmon, Matthew, Daisy M. Ramos, Nithyadevi Duraisamy, et al.. (2020). Growing a backbone – functional biomaterials and structures for intervertebral disc (IVD) repair and regeneration: challenges, innovations, and future directions. Biomaterials Science. 8(5). 1216–1239. 38 indexed citations

Borno, Hala T., Kelvin A. Moses, Paul Monk, et al.. (2020). Sipuleucel-T (sip-T) and oral androgen axis inhibitors in black men being treated for metastatic castration-resistance prostate cancer (mCRPC): Observations from the Medicare Fee for Service (FFS) population.. Journal of Clinical Oncology. 38(15_suppl). e17589–e17589. 1 indexed citations

Zhang, Jingsong, Ming Liu, Jiahua Pan, et al.. (2020). Real-world experience with sipuleucel-T (Sip-T) in Asian men with castrate-resistant prostate cancer (CRPC).. Journal of Clinical Oncology. 38(15_suppl). e17588–e17588. 1 indexed citations

Sartor, Oliver, Andrew J. Armstrong, Chiledum Ahaghotu, et al.. (2020). Abstract D084: Overall survival (OS) of African-American (AA) and Caucasian (CAU) men who received sipuleucel-T for metastatic castration-resistant prostate cancer (mCRPC)—final PROCEED analysis. Cancer Epidemiology Biomarkers & Prevention. 29(6_Supplement_2). D084–D084. 1 indexed citations

Moses, Kelvin A., Scott C. Flanders, Matthew Harmon, et al.. (2019). Interpreting survival outcomes for African-American (AA) patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) treated with sipuleucel-T (SIP-T) with number needed to treat to benefit (NNTB).. Journal of Clinical Oncology. 37(7_suppl). 222–222.

Sartor, Oliver, Andrew J. Armstrong, Chiledum Ahaghotu, et al.. (2019). Overall survival (OS) of African-American (AA) and Caucasian (CAU) men who received sipuleucel-T for metastatic castration-resistant prostate cancer (mCRPC): Final PROCEED analysis.. Journal of Clinical Oncology. 37(15_suppl). 5035–5035. 6 indexed citations

Vogelzang, Nicholas J., Philip W. Kantoff, Mark C. Scholz, et al.. (2019). Experience with sipuleucel-T in metastatic castration-resistant prostate cancer (mCRPC) with visceral spread from PROCEED.. Journal of Clinical Oncology. 37(7_suppl). 174–174. 1 indexed citations

10.

Jaiswal, Devina, Roshan James, Namdev B. Shelke, et al.. (2015). Gelatin Nanofiber Matrices Derived from Schiff Base Derivative for Tissue Engineering Applications. Journal of Biomedical Nanotechnology. 11(11). 2067–2080. 12 indexed citations

11.

Henderson, Nancy, Matthew Harmon, & Cathy Xiaoyan Zhong. (2015). PCR-Based Detection and Quantification of a Transgenic Glyphosate-Tolerant Canola Using a Novel Reference Gene System. Food Analytical Methods. 9(2). 353–361. 7 indexed citations

12.

Gahr, Scott A., Frank P. Thrower, Matthew Harmon, et al.. (2014). Mapping and Expression of Candidate Genes for Development Rate in Rainbow Trout (Oncorhynchus mykiss). Journal of Heredity. 105(4). 506–520. 7 indexed citations

13.

Nada, Ahmed A., Roshan James, Namdev B. Shelke, et al.. (2014). A smart methodology to fabricate electrospun chitosan nanofiber matrices for regenerative engineering applications. Polymers for Advanced Technologies. 25(5). 507–515. 56 indexed citations

14.

James, Roshan, Matthew Harmon, Sangamesh G. Kumbar, & Cato T. Laurencin. (2014). INNOVATIVE REGENERATIVE ENGINEERING TECHNOLOGIES FOR SOFT TISSUE REGENERATION. Technology & Innovation. 16(3). 195–214. 2 indexed citations

15.

Aravamudhan, Aja, Daisy M. Ramos, Matthew Harmon, et al.. (2013). Cellulose and Collagen Derived Micro-Nano Structured Scaffolds for Bone Tissue Engineering. Journal of Biomedical Nanotechnology. 9(4). 719–731. 80 indexed citations

16.

Aravamudhan, Aja, Daisy M. Ramos, Roshan James, et al.. (2013). Osteoinductive Small Molecules: Growth Factor Alternatives for Bone Tissue Engineering. Current Pharmaceutical Design. 19(19). 3420–3428. 79 indexed citations

17.

Harmon, Matthew, Roshan James, Namdev B. Shelke, & Sangamesh G. Kumbar. (2013). Synthesis and characterization of poly(caprolactone triol succinate) elastomer for tissue engineering application. Journal of Applied Polymer Science. 130(5). 3770–3777. 9 indexed citations

18.

Patel, Chirag G., Matthew Harmon, Reginald Gohh, & Fatemeh Akhlaghi. (2007). Concentrations of Mycophenolic Acid and Glucuronide Metabolites Under Concomitant Therapy With Cyclosporine or Tacrolimus. Therapeutic Drug Monitoring. 29(1). 87–95. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact